ACTiVION-II, the first of two US Phase 3 clinical trials, did not meet co-primary endpoints of VAS pain score and WOMAC total score at Month 12Results from ACTiVION-I, the second Phase 3 trial of TG-C ...

Toyota’s new bZ electric SUV is nearly outselling the Prius this year. With an extra $3,000 off if you trade in your old EV ...

Des Moines University Medicine and Health Sciences faculty member Elitsa Ananieva, PhD, has led a study that could help improve the effectiveness of cancer immunotherapies by ...

Music education helps us develop our executive function skills to plan, behave, and make smart decisions through honing our ...

Autonomous drone fleet management startup Tesseract Ventures was selected by the Defense Innovation Unit for the Pentagon’s ...

Peer-Reviewed Letter to the Editor Describes Updated Long-Term Findings Consistent with Initial Trial Data Featured in NEJM Article Published in 2025 ...

Excitement is continuing to build for the Advocates Online Townsville Chamber Business Awards 2026 following a successful ...

New York Gov. Kathy Hochul is vowing to cut "red tape" in state government with a new plan she says will reduce bureaucracy ...

Learn the important Racket concepts with practical examples, from functions and recursion to macros, contracts, streams, and ...

Australia’s crash-test watchdog has delivered a brutal warning to global car giants to bring back physical buttons, or risk ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced topline results from its Phase 2 study evaluating ...

GigaWiper is a destructive backdoor that combines multiple wiping and ransomware-like capabilities into a single operational ...